Navigation Links
Arthritis Pain Can Be Eased Using Snake Venom

Scientists have found that snake venom can be used for easing the debilitating pain from arthritis. //

Naftali Primor, research and development manager at the Shulov Institute of Sciences (SIS) in Israel where the research is being carried out, believes that an analgesic based on snake venom could be on sale within five years.

The researchers studied the Palestinian viper - the most common snake in Israel - and said people suffering from arthritis could get relief using a cream made of chemicals found in snake venom, reported the online edition of Daily Mail.

Primor said: "About 99 percent of the venom is non-toxic, which leaves us with a great source of possible drug components. A snake venom pain-relieving cream could be on sale within five years."

The researchers believe that other chemicals found in snake venom could be exploited to make drugs to treat diseases such as cancer.

They found that out of every 1,000 molecules present in the venom, only four or five were poisonous. They isolated one of the molecules, which had analgesic properties and made a safe, synthetic copy called VeP-3.

The Arthritis Research Campaign said they had heard of examples of people with arthritis being bitten by snakes and having their pain reduced.

"Similarly, others have reported the same effect from bee stings and nettles and it appears that all venom and stings have some kind of pain-relieving properties," spokesperson Jane Tadman added.

"Obviously people shouldn't seek out adders to bite them on the off-chance that it might help their arthritis, but a synthetic form of venom minus the toxins might be the answer," she said.

--Edited IANS
'"/>




Page: 1

Related medicine news :

1. Another ray of hope for Arthritis Sufferers
2. Naked DNA Vaccination May Conquer Arthritis and Multiple Sclerosis
3. B Vitamin protects and lowers toxicity of Arthritis Drug
4. FDA Approves New Arthritis Drug, Bextra
5. Risk Of Developing Arthritis
6. Arthritis Drug May Cause Liver Damage
7. Arthritis drug can prolong life
8. New treatment for Rheumatoid Arthritis
9. Important cause of Arthritis
10. Personality Impacts Arthritis
11. New Rheumatoid Arthritis Treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/22/2017)... ... August 22, 2017 , ... TopConsumerReviews.com recently gave a ... fight Fatigue . , As the stress of modern life continually makes more demands ... Constant use of artificial stimulants can trap people in vicious high/low cycles and can ...
(Date:8/22/2017)... ... 22, 2017 , ... Although Labor Day is not as popular for fireworks ... weekend displays, and numerous households celebrate the unofficial end of summer with backyard fireworks ... pets. , Kris Zambo, owner of Dynamite Fireworks in Hammond, Indiana, ...
(Date:8/21/2017)... ... August 22, 2017 , ... ... risk to health and safety. By learning and implementing best practices for containment ... In this webinar, attendees will gain a better understanding of a method for ...
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... ... the addition of two plastic surgery fellows for academic year 2017-2018, Christina M. ... candidates who have successfully completed residency in Plastic and Reconstructive Surgery. The ...
(Date:8/21/2017)... ... August 21, 2017 , ... SportsEngine, Inc. , ... Official Technology Partner of North Country Region Volleyball and will power registration, scheduling, ... along with providing sport management software to their member clubs. , ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017  Axium Pharmaceuticals Inc., the creator of ... to be in the beginning stages of an IPO. ... epilepsy medications with the average cost of a prescription epilepsy drug being ... AXIUM ... Another staggering figure is the fact that ...
(Date:8/14/2017)... N.J. and PETACH TIKVAH, Israel ... Inc. (NASDAQ: BCLI), a leading developer of adult stem ... the second quarter ending June 30, 2017. ... stages of preparing for our pivotal Phase 3 trial ... Chaim Lebovits , President and Chief Executive Officer of ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
Breaking Medicine Technology: